Drugs company sold to AstraZeneca

Tue, 29 Oct 2013 | BUSINESS SALE

A drugs company that specialises in anti-cancer medication has been sold to AstraZeneca.

Founded by a scientist from the University of Portsmouth and a former student, the business – Spirogen Ltd - was born out of research projects that are now approaching fruition.

The firm is developing drugs that target cancer without destroying healthy cells. It has some drugs in Phase II clinical trials, including a DNA binding drug that could be used in the treatment of ovarian cancer and leukaemia.

Spirogen was co-founded in 2000 by David Thurston, who now works as a Professor of Drug Discovery at King's College London. He previously founded the Institute of Biomedical and Biomolecular Sciences (IBBS) with Professor Geoff Kneale.

Professor Kneale commented on the development: “I am delighted that Spirogen has been so successful in developing these novel compounds, first designed and synthesised by Professor Thurston and colleagues here at Portsmouth.  
“It is very rewarding when the fundamental research we started in IBBS many years ago is translated into the clinic. It gives me great confidence that much of the research we are currently engaged in will find equally successful clinical applications, with a real impact on people’s lives.”

The sale has gone through for £124 million.

Related information:
View the latest medical and educational businesses for sale

Share this article

Latest Businesses for Sale

Courier Business
UK Wide

Long-established courier business, which has an excellent reputation for providing a bespoke and rapid response service to its loyal client base. Established 20 years+. Excellent reputation for speedy, flexible and efficient service, 365 days of the...

Asking Price: Offers Invited
Turnover: £600,000


Manufacturer & Retailer of Textiles
UK Wide

This long established company is a second generation family business specialising in the design, manufacture, installation and retailing of blinds, fabrics and wallpapers. Offers invited.

Asking Price: Offers Invited
Turnover: £500,000


Microsoft Independent Software Vendor Partner
Midlands, UK Wide

Microsoft 365 ISV & Services Partner – Healthcare and Public Sector. An opportunity has arisen to purchase an established Microsoft Independent Software Vendor Partner (ISV) providing Software, ‘SaaS’ and Services for Microsoft 365 Information Manage...

Asking Price: Offers Invited
Turnover: £1,200,000

View more businesses for sale

News Search

Latest News


Aviation claims specialist enters administration | ADMINISTRATION

Didsbury-based aviation claims specialist Flight Reclaim has...


Next completes sale and leaseback of head office and warehouses | COMMERCIAL PROPERTY

High street fashion retailer Next Plc has confirmed the succ...


Benchmark Holdings secures sale of veterinary business | BUSINESS SALE

Sheffield-headquartered aquaculture health, nutrition and ge...

Free guide: 10 Biggest Buyer Mistakes

Sign up to receive our acquisition alert emails to get your FREE guide


Related News


Pharmaceutical manufacturer enters administration | ADMINISTRATION

A pharmaceutical manufacturing company based in Bristol has ...

Want access to the latest businesses for sale?

Business Sale Report is your complete solution to finding great acquisition opportunities.

Join today to receive:

  • Comprehensive range of businesses for sale
  • Make direct contact with business sellers or their intermediaries
  • Access to all UK administrations, liquidations and winding-up petitions
  • Daily email alerts for the latest businesses for sale & distressed notifications
  • Business Sale Report publication posted to you every month
  • Advertise your acquisition requirements on our "business wanted" section

All this and much more, including the latest M&A news and exclusive resources